
Patients with left zzso dysfunction zzso are at increased risk for dying suddenly of cardiac zzso The most common causes of zzso are coronary artery disease zzso and zzso zzso zzso zzso intervention following zzso is essential for minimizing the zzso damage that leads to zzso and the subsequent risk for heart failure and sudden cardiac zzso This article describes practical zzso for managing the patient post zzso to minimize such zzso The degree of zzso is a key factor for determining clinical management strategies in the patient post zzso zzso factor reduction and selective zzso zzso especially with zzso zzso zzso are usually recommended in the presence or absence of zzso along with early use of a beta zzso In patients with zzso more aggressive intervention includes extended use of a beta zzso In cases of zzso progressed to heart failure, the mixed beta and alpha blocker zzso has improved outcomes zzso In clinical trials, zzso has been demonstrated to have zzso activity, a property that offers protection against sudden zzso death in high-risk patients with zzso zzso of an zzso zzso is also advised in patients with heart zzso In selected patients with reduced ejection zzso use of zzso treatment and device therapy offers further zzso 

